Drimva

GSK

SERM Scientific Director, Oncology

$170K–$283K

USA - Pennsylvania - Upper Providence +3 · Hybrid (Remote & On-site) · Director · Full-time · Posted Oct 27, 2026

Location
USA - Pennsylvania - Upper Providence
USA - Massachusetts - Waltham
Rockville Tower Oaks Blvd
Durham Blackwell Street
Experience
Advanced experience: 5+ years in the Pharmaceutical or Biotech industry working in Pharmacovigilance or Drug Safety.
Education
Bachelor of Science in Life Sciences or Medical Sciences (minimum standard); PharmD/PhD for Scientist (preferred).

About the job

Leads oncology pharmacovigilance and risk management, overseeing safety evaluation, governance, regulatory submissions, and risk-reduction strategies across clinical development and post-marketing products.

What you'll do

  • Develops pharmacovigilance and risk management strategy, evaluates safety data, and leads safety components of global regulatory submissions.
  • Leads cross-functional safety governance, detects and addresses product safety issues, and ensures risk-reduction strategies are implemented.
  • Presents safety recommendations to senior governance groups and represents GSK in regulatory and external discussions.

What they ask for

  • Bachelor of Science in Life Sciences or Medical Sciences (minimum standard); PhD/PharmD preferred for Scientist.
  • Advanced experience (5+ years) in the Pharmaceutical or Biotech industry in Pharmacovigilance or Drug Safety.
  • Significant pharmacovigilance experience in Safety Evaluation and Risk Management, covering clinical development and post-marketing activities.
  • Experience with Signal Detection and safety surveillance; knowledge or experience of international pharmacovigilance requirements and drug development and approval processes.

Nice to have

  • PharmD/PhD for Scientist.
  • Experience working in large matrix organizations.

Pay

$169,950 to $283,250 USD annual base salary

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 5, 2026 (UTC)